Literature DB >> 8216132

Limitations of CA125 in the preoperative evaluation of a pelvic mass: struma ovarii and ascites.

Y C Leung1, I G Hammond.   

Abstract

This report discusses the limitations of using the serum tumour marker CA 125 in the preoperative evaluation of a woman presenting with a pelvic mass. We present 2 cases of benign struma ovarii which were associated with elevated levels of CA 125.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216132     DOI: 10.1111/j.1479-828x.1993.tb02400.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  6 in total

1.  Struma ovarii associated with pseudo-Meigs' syndrome and elevated serum CA 125: a case report and review of the literature.

Authors:  Wei Jiang; Xin Lu; Zhi Ling Zhu; Xi Shi Liu; Cong Jian Xu
Journal:  J Ovarian Res       Date:  2010-07-29       Impact factor: 4.234

Review 2.  Struma Ovarii with Pseudo-Meigs' Syndrome and Raised Cancer Antigen-125 Levels Masquerading as an Ovarian Carcinoma Case report and literature review.

Authors:  Surekha Yadav; Reena Tomar; Nidhi Verma; Nita Khurana; Rewa Triathi
Journal:  Sultan Qaboos Univ Med J       Date:  2017-06-20

3.  Clinical characteristics of struma ovarii.

Authors:  Seung-Chul Yoo; Ki-Hong Chang; Mi-Ok Lyu; Suk-Joon Chang; Hee-Sug Ryu; Haeng-Soo Kim
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

4.  Struma ovarii: role of imaging?

Authors:  Martine I Dujardin; Priti Sekhri; Lindsay W Turnbull
Journal:  Insights Imaging       Date:  2013-12-20

5.  Treatment and follow-up of malignant struma ovarii: Regarding two cases.

Authors:  Aurore Oudoux; Eric Leblanc; Juliette Beaujot; Hélène Gauthier-Kolesnikov
Journal:  Gynecol Oncol Rep       Date:  2016-06-08

Review 6.  Precise preoperative diagnosis of struma ovarii with pseudo-Meigs' syndrome mimicking ovarian cancer with the combination of 131I scintigraphy and 18F-FDG PET: case report and review of the literature.

Authors:  Sayaka Fujiwara; Hideaki Tsuyoshi; Toshiya Nishimura; Nozomu Takahashi; Yoshio Yoshida
Journal:  J Ovarian Res       Date:  2018-02-02       Impact factor: 4.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.